| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |